Standout Papers
- CTLA-4 is a second receptor for the B cell activation antigen B7. (1991)
- Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 (1992)
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors (1994)
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome (1993)
- T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. (1990)
Immediate Impact
130 by Nobel laureates 96 from Science/Nature 214 standout
Citing Papers
Neoadjuvant checkpoint blockade for cancer immunotherapy
2020 StandoutScience
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
Works of J A Ledbetter being referenced
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
1994 Standout
CTLA-4 is a second receptor for the B cell activation antigen B7.
1991 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J A Ledbetter | 6094 | 1053 | 1443 | 1881 | 41 | 7.7k | |
| R H Schwartz | 4922 | 1175 | 1178 | 1078 | 47 | 6.2k | |
| Nitin K. Damle | 4628 | 1312 | 1111 | 1725 | 73 | 6.8k | |
| Daniel L. Mueller | 4890 | 544 | 1507 | 1255 | 82 | 6.6k | |
| Jane A. Gross | 4316 | 830 | 1074 | 1259 | 30 | 6.1k | |
| P S Linsley | 4922 | 618 | 725 | 1209 | 23 | 6.0k | |
| Shixin Qin | 6359 | 427 | 1166 | 2883 | 48 | 9.0k | |
| Laura S. Grosmaire | 3875 | 687 | 800 | 917 | 39 | 4.9k | |
| Matthew L. Thomas | 4929 | 741 | 3227 | 1055 | 64 | 6.9k | |
| Bryan Irving | 5377 | 903 | 1692 | 3981 | 43 | 7.6k | |
| S F Schlossman | 3318 | 1365 | 1450 | 1315 | 60 | 5.5k |
All Works
Loading papers...